Global Blood Collection Devices Market Outlook, 2031
The Global Blood Collection Devices Market is segmented into By Product Type (Blood Collection Tubes, Needles & Syringes, Blood Bags, Blood Collection Systems/Monitors, Lancets, Others); By End-User (Hospitals and ASCs, Diagnostics and Pathology Laboratories, Blood Banks, Others); By Application (Diagnostic Application, Therapeutic Application); By Method (Manual, Automated).
- Bonafide Research
- 02-09-2026
- Pages : 198
- Figures : 36
- Tables : 112
- Region : Global
- Category : Lifescience & Healthcare
- Medical Devices
- Schedule a Call
-
Sikandar Kesari — Research Analyst
The Global Blood Collection Devices Market is expected to cross USD 13.08 Billion market size by 2031, with 7.14% CAGR by 2026-31, driven by the prevalence of diseases.
- Historical Period2020-2024
- Base Year2025
- Forecast Period2026-2031
- Market Size (2025) USD 8.73 Billion
- Market Size (2031) USD 13.08 Billion
- CAGR (2026-2031) 7.14%
- Largest MarketNorth America
- Fastest Market Asia-Pacific
- Format
Featured Companies
- 1. Medline Industries, LP
- 2. Beckton Dickinson
- 3. Cardinal Health, Inc.
- 4. Abbott Laboratories
- 5. ICU Medical Inc.
- 6. McKesson Corporation
- 7. Terumo Corporation
- 8. Nipro Corporation
- 9. Thermo Fisher Scientific Inc
- More...
Blood Collection Devices Market Analysis
The global blood collection devices market encompasses specialized medical tools including evacuated collection tubes, safety needles, blood bags, lancets, and automated collection systems designed to extract, transport, and preserve blood for diagnostic and therapeutic procedures. Valued over billion globally, this market forms a vital cornerstone of modern clinical infrastructure, enabling routine disease screening, blood transfusion networks, liquid biopsy testing, and clinical trial workflows across healthcare facilities. Its profound relevance and importance rest on the reality that accurate laboratory diagnostics depend entirely on standardized, uncompromised pre-analytical specimen collection. Growth drivers include a rising global prevalence of chronic conditions like diabetes, cardiovascular disorders, and cancer, an expanding aging population, increasing awareness of early disease detection, and stringent international occupational mandates requiring safety-engineered devices to protect clinicians from needle-stick injuries. Additionally, the expansion of decentralized point-of-care diagnostics, micro-sampling, and home blood testing further accelerates market expansion. Key global professional organizations and regulatory authorities such as the World Health Organization (WHO), the Clinical and Laboratory Standards Institute (CLSI), the International Society of Blood Transfusion (ISBT), and the American Association of Blood Banks (AABB) play a central role in shaping the market landscape. These associations establish standardized phlebotomy protocols, enforce specimen handling guidelines, host technical educational symposia, and set global accreditation standards for blood banks and reference laboratories. Their collective activities encourage manufacturers to innovate automated, eco-friendly, and push-button collection tools, ultimately reducing pre-analytical diagnostic errors, elevating clinical biosafety, and ensuring consistent blood specimen integrity across both developed and emerging healthcare systems worldwide. According to the research report, “Global Blood Collection Devices Market Overview, 2031” published by Bonafide Research, the Global Blood Collection Devices Market is expected to cross USD 13.08 Billion market size by 2031, with 7.14% CAGR by 2026-31. The global blood collection devices market is a highly consolidated sector led by major multinational players, including Becton, Dickinson and Company (BD), Terumo Corporation, Fresenius Kabi, Greiner Bio-One, Nipro Corporation, and Sarstedt AG. Generating multi-billion-dollar global revenues, the industry's continuous expansion is anchored by routine diagnostic testing, transfusion networks, and surgical procedures. Notable company developments focus on safety-engineered technology and laboratory automation; BD continues to innovate its signature evacuated tube systems and microtainers, while Terumo and Fresenius advance automated apheresis collection systems to optimize plasma and component separation. Substantial growth opportunities exist in non-invasive micro-sampling, push-button capillary devices, and RFID-integrated sample tracking designed to prevent pre-analytical errors in high-throughput reference labs. Supply chain dynamics rely on precision raw materials such as medical-grade polymers, borosilicate glass, synthetic rubbers, and stainless steel sourced from specialized chemical and metallurgical suppliers. These components undergo automated injection molding, chemical additive coating, and gamma-radiation sterilization at centralized regional manufacturing hubs in North America, Europe, and Asia. Finished consumables, such as vacuum tubes, lancets, and safety needles, are then distributed globally through healthcare suppliers and public tender channels. However, supply chain vulnerabilities remain prominent; fluctuating petrochemical prices, global transport cold-chain requirements for pre-additive tubes, and sudden disruptions in raw plastic resin supplies present operational challenges for manufacturers worldwide.
to Download this information in a PDF
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Dynamics
Market Drivers
• Surging global disease burden and expanding diagnostic & preventive screening volume: The fundamental growth engine for the global blood collection devices market is the accelerating prevalence of chronic conditions such as cardiovascular diseases, type-2 diabetes, autoimmune disorders, and various cancers alongside recurring infectious disease threats. Clinical management and early detection of these conditions depend on blood testing for complete blood counts (CBCs), metabolic panels, lipid profiles, and molecular biomarkers. Additionally, expanding healthcare access in emerging economies and government-led preventive screening initiatives (e.g., routine metabolic health checks, prenatal screening, and donor infectious disease screening) consistently boost blood draw volumes.• Strict international biosafety mandates and adoption of safety-engineered devices: Occupational safety regulations and clinical guidelines enforced by bodies like the U.S. OSHA (via the Needlestick Safety and Prevention Act), EU Directive 2010/32/EU, and the World Health Organization (WHO) drive global demand for premium safety-engineered devices. Healthcare institutions are legally and procedurally mandated to adopt safety needles featuring active/passive shielding mechanisms, self-retracting lancets, and closed evacuated tube systems to eliminate accidental needle-stick injuries and prevent exposure to blood-borne pathogens such as HIV, Hepatitis B, and Hepatitis C. This global regulatory push continues to phase out basic non-safety needles in favor of higher-value, regulatory-compliant safety consumables, providing a sustained tailwind for market revenue growth.
Market Challenges
• Product commoditization, price pressures, and raw material supply chain volatility: Because baseline blood collection devices (standard evacuated tubes, syringes, and basic lancets) are largely viewed as high-volume commoditized consumables, manufacturers face intense pricing pressure from large hospital procurement networks and centralized state-run tender systems. This price erosion compresses profit margins, particularly for mid-sized suppliers. Compounding this challenge is the ongoing volatility in the global supply chain for high-purity raw materials, including medical-grade polymers, borosilicate glass, synthetic rubber stoppers, and stainless steel. Industrial energy fluctuations, transport cold-chain requirements for delicate chemical-additive tubes, and strict regional regulatory compliance audits (such as EU MDR or US FDA standards) add layers of logistical friction and cost inflation for manufacturers.• Global shortage of skilled phlebotomists and high pre-analytical error rates: A critical operational bottleneck facing the global market is the persistent workforce deficit of certified phlebotomists, laboratory technicians, and specialized nurses. High clinician turnover, burnout, and training backlogs leave diagnostic centers and hospital networks short-staffed. This shortage exacerbates the risk of pre-analytical errors such as sample hemolysis, improper blood-to-additive ratios, tube contamination, or incorrect patient identification. Pre-analytical failures compromise specimen integrity, leading to high sample rejection rates, delayed lab results, repeated blood draws, and wasted collection consumables, which strain operational workflows across both developed and developing healthcare systems.
Market Trends
• Rapid expansion of micro-sampling, capillary collection, and at-home diagnostics: The market is experiencing a major technological pivot from traditional, high-volume venipuncture toward minimally invasive capillary micro-sampling. Micro-sampling innovations including push-button upper-arm devices, volume-exact micro-containers, and dried blood spot (DBS) collection technology allow the extraction of micro-liter volumes of blood with minimal pain. Driven by the growth of decentralized clinical trials, telemedicine, remote patient monitoring, and home diagnostic testing kits, micro-sampling enables self-collection or easy administration by non-specialists.• Accelerated integration of automation, RFID tracking, and smart apheresis systems: To overcome phlebotomy labor shortages and streamline diagnostic throughput, high-volume donor centers and pathology reference labs are rapidly integrating smart and automated collection technologies. In therapeutic and donor phlebotomy, automated apheresis platforms optimize blood component separation (plasma, platelets, red blood cells) at the point of draw, drastically reducing draw times and improving donor safety. Simultaneously, manufacturers are embedding RFID microchips and 2D high-density barcodes directly onto collection tubes. These smart consumables automatically log draw timestamps, specimen volumes, and temperature exposure into hospital information systems (HIS), creating a seamless digital chain-of-custody that eliminates manual labeling errors and elevates pre-analytical precision.
Blood Collection Devices Segmentation
| By Product Type | Blood Collection Tubes | |
| Needles & Syringes | ||
| Blood Bags | ||
| Blood Collection Systems/Monitors | ||
| Lancets | ||
| Others | ||
| By End-User | Hospitals and ASCs | |
| Diagnostics and Pathology Laboratories | ||
| Blood Banks | ||
| Others | ||
| By Application | Diagnostic Application | |
| Therapeutic Application | ||
| By Method | Manual | |
| Automated | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Russia | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
| MEA | United Arab Emirates | |
| Saudi Arabia | ||
| South Africa | ||
Blood collection tubes are the largest product segment because they are essential, routinely consumed components required to safely collect, preserve, transport, and prepare blood specimens for laboratory testing. Blood collection tubes occupy a central position in blood collection because virtually every venous blood specimen intended for laboratory analysis must be placed into an appropriate tube before testing or processing. Unlike reusable equipment, tubes are generally single-use consumables, so their utilization is directly connected to the volume of blood samples collected in hospitals, outpatient laboratories, physician practices, diagnostic centers, and other healthcare settings. Different investigations require different tube characteristics, including specific additives, anticoagulants, clot activators, separator gels, or specialized preservatives. For example, EDTA tubes are widely used for hematology testing because EDTA helps preserve cellular components and is commonly used for complete blood counts, while citrate tubes are used for coagulation investigations because they control clotting during specimen handling. Serum separator tubes are frequently used for chemistry and immunology testing because the gel helps separate serum from cellular components after centrifugation. This need for test-specific tubes creates repeated demand across a broad range of diagnostic procedures. Tubes also contribute to specimen quality by providing controlled environments that help maintain sample integrity between collection and laboratory analysis. Standardized tube designs, color coding, fill requirements, additive concentrations, labeling systems, and compatibility with laboratory analyzers support consistent workflows and reduce avoidable specimen-handling errors. In addition, modern healthcare systems perform extensive preventive screening, chronic disease monitoring, emergency testing, surgical evaluations, and therapeutic monitoring, all of which require blood specimens. As laboratories increasingly rely on standardized pre-analytical processes, correctly selected collection tubes remain an important first step in producing reliable test results. Hospitals and ambulatory surgical centers are the largest end-user segment because they perform large volumes of diagnostic, preoperative, perioperative, postoperative, emergency, and monitoring procedures that routinely require blood specimen collection. Hospitals and ambulatory surgical centers have an unusually broad requirement for blood collection because patients undergo multiple stages of clinical assessment before, during, and after treatment. In hospitals, blood specimens are collected in emergency departments, inpatient wards, intensive care units, operating rooms, outpatient departments, oncology services, maternity units, and specialized clinical departments. These settings require blood testing for purposes such as assessing blood cell counts, electrolyte and metabolic status, organ function, coagulation, infection-related indicators, blood compatibility, medication monitoring, and other clinical evaluations. Blood collection is therefore integrated into both routine patient management and urgent decision-making. Before many surgical procedures, laboratory investigations are performed to evaluate a patient's general condition and identify issues that could affect anesthesia or surgery, while postoperative testing can be used to monitor recovery and detect complications. Ambulatory surgical centers also contribute to demand because patients undergoing procedures that do not require overnight hospitalization commonly undergo preoperative screening and selected postoperative assessments. Another important factor is the concentration of trained clinical personnel and established phlebotomy infrastructure within these facilities. Hospitals typically maintain dedicated laboratories, specimen transport systems, blood banks, electronic medical records, barcode identification processes, and established protocols for collection and handling. These systems allow blood specimens to move efficiently from the patient to the laboratory while maintaining identification and traceability. Diagnostic applications lead because blood collection is fundamentally tied to laboratory testing used to identify, confirm, classify, monitor, and manage a wide range of diseases and clinical conditions. Diagnostic testing is one of the most frequent reasons a healthcare professional collects a patient's blood, making diagnostic applications a natural primary use of blood collection devices. A blood specimen can provide information about hematological, biochemical, metabolic, hormonal, immunological, infectious, and coagulation-related conditions, among many other areas of clinical medicine. Tests such as complete blood counts require carefully collected whole blood, while clinical chemistry investigations commonly use serum or plasma prepared from appropriately collected specimens. Coagulation testing requires particular attention to the collection tube, additive, blood-to-anticoagulant ratio, and specimen volume because variations in pre-analytical conditions can influence test performance. Blood samples are also used in diagnostic investigations involving glucose, liver and kidney function, lipid levels, electrolytes, antibodies, hormones, inflammatory indicators, and infectious disease markers. This broad analytical range creates demand for different collection tubes and associated devices because one tube configuration cannot satisfy every laboratory requirement. Diagnostic blood collection also occurs across multiple points of care. Primary care visits may generate specimens for routine screening, while hospitals and laboratories process samples associated with acute illness, chronic disease management, preventive care, and follow-up testing. The importance of diagnostic accuracy means that the pre-analytical stage cannot be separated from the quality of the final laboratory result. Proper patient identification, correct tube selection, appropriate collection technique, adequate filling, mixing where required, and timely transport are all important elements of specimen integrity. Manual blood collection remains the largest method segment because venipuncture performed directly by trained healthcare professionals is a flexible, widely established technique that can be used across diverse patient conditions and healthcare environments. Manual blood collection, particularly conventional venipuncture, remains deeply embedded in routine clinical practice because it can be performed with relatively simple equipment and does not require a fully automated blood-drawing system. A trained phlebotomist, nurse, physician, or other qualified healthcare professional can select an appropriate vein, apply a tourniquet, prepare the collection site, insert a needle, and fill the required tubes according to the laboratory order. This flexibility is important because patients differ considerably in age, vascular condition, body characteristics, clinical status, and treatment history. A healthcare professional can adapt the procedure when a vein is difficult to access, when a particular collection site is unsuitable, or when specimen requirements change during the encounter. Manual collection is also compatible with standard evacuated tube systems, winged blood collection sets, syringes, and other commonly used devices. Another reason for its widespread use is the established infrastructure surrounding the procedure. Healthcare professionals are trained in venipuncture, specimen identification, tube order, infection-control practices, sharps safety, and specimen handling, allowing manual collection to be integrated into existing workflows without requiring major technological changes. Manual procedures can also be carried out in environments ranging from major hospitals and laboratories to outpatient clinics, physician offices, community collection sites, and smaller healthcare facilities. Although automated technologies can support certain stages of specimen processing or collection, fully automated blood-drawing systems face practical challenges involving patient positioning, vein variability, difficult access, equipment requirements, and the need for clinical judgment. Blood collection also frequently occurs during encounters where the number of tubes, testing requirements, or patient circumstances vary.
to Download this information in a PDF
Blood Collection Devices Market Regional Insights
North America is the leading region because its mature healthcare infrastructure, extensive laboratory-testing activity, established phlebotomy practices, and strong adoption of standardized medical consumables support widespread use of blood collection devices. North America has a highly developed healthcare system in which blood collection is integrated into hospital care, outpatient medicine, emergency services, preventive screening, chronic disease management, surgery, and specialized laboratory diagnostics. The United States and Canada have extensive networks of hospitals, physician practices, diagnostic laboratories, outpatient facilities, and specialized treatment centers, creating numerous locations where blood specimens are routinely collected. Clinical laboratories in the region process specimens for a broad range of applications, including hematology, chemistry, immunology, microbiology-related investigations, coagulation, therapeutic monitoring, and disease screening. The region also has well-established standards governing specimen collection, identification, transportation, infection control, and laboratory quality. • USA: The United States is the largest country-level segment in the North American blood collection devices market because its extensive healthcare infrastructure, large clinical laboratory network, high level of healthcare utilization, and strong diagnostic capacity generate broad and recurring demand for blood specimen collection. The American Hospital Association reported 6,093 hospitals in its 2026 Fast Facts publication, illustrating the breadth of hospital infrastructure across the country. The U.S. also has an extensive regulated clinical laboratory environment.
to Download this information in a PDF
Key Development
- January 2026Terumo launched the Venosafe II Replot vacuum blood collection tube in Japan, designed to accelerate clot formation and reduce laboratory turnaround time.
- December 2025Hims & Hers announced an agreement to acquire YourBio Health, aiming to scale pain-free, at-home capillary blood sampling using YourBio’s microneedle-based technology.
- October 2025Fresenius Kabi announced 13 New Inductees into the National Blood Donation Hall of Fame, highlighting leadership in blood collection bags and devices used by blood banks and healthcare facilities.
- October 2025Capitainer and Life Genomics signed a partnership to expand home-based testing using Capitainer’s self-sampling technology (a step toward broader consumer/clinical deployment of controlled-volume home sampling).
- March 2025Shin Nippon Biomedical Laboratories, Tasso, Inc., the market leader for patient-centric blood collection and the Seattle-based company based behind it, jointly disclosed the launch of a new joint venture in Japan. Under terms of the venture, the partnership will be the sole channel for marketing Tasso’s single‑use.
- March 2025Vitestro unveiled an autonomous robotic system for blood collection, named Aletta Jacobs in honor of the Netherlands’ first female physician. The device is designed to optimize the blood draw process, enhancing efficiency and patient experience.
- Feb 2025Tasso launched its next-generation dried blood spot (DBS) collection system (Tile-T20 cartridge + Tasso Mini), targeting patient-centric DBS collection for remote clinical trials and related workflows.
- January 2025Terumo BCT signed a Memorandum of Understanding (MoU) on a strategic partnership with the Shandong Institute of Medical Devices and Pharmaceutical Packaging Inspection. This partnership will strengthen technical research and innovation, with emphasis on Terumo BCT's strategic product areas, including blood component collection.
- January 2025Fresenius secured FDA 510(k) Clearance for the Adaptive Nomogram to Improve Plasma Collection Efficiency.
- December 2024BD, along with Babson Diagnostics, launched the BD MiniDraw Capillary Blood Collection System, which incorporates Babson's BetterWay technologies to enable test results from as few as six drops of capillary blood collected from a patient's finger.
- February 2024Tasso, Inc. launched Tasso Care for Prescreening, a new comprehensive service that helps streamline prescreening. This new offering builds on the company’s Tasso Care platform, leveraging technology and expertise previously developed for remote blood collection and diagnostic testing.
Companies Mentioned
- Medline Industries, LP
- Beckton Dickinson
- Cardinal Health, Inc.
- Abbott Laboratories
- ICU Medical Inc.
- McKesson Corporation
- Terumo Corporation
- Nipro Corporation
- Thermo Fisher Scientific Inc
- QIAGEN N.V.
- Retractable Technologies Inc.
- Sarstedt AG & Co. KG
- SB-Kawasumi Laboratories, Inc.
- Greiner Holding AG
- Fresenius Kabi AG
- Haemonetics Corporation
- Sol-Millennium Medical Group
- F.L. Medical S.r.l.
- Macopharma S.A.
- Sekisui Medical Co., Ltd.
Table of Contents
- 1. Executive Summary
- 2. Market Dynamics
- 2.1. Market Drivers & Opportunities
- 2.2. Market Restraints & Challenges
- 2.3. Market Trends
- 2.4. Supply chain Analysis
- 2.5. Policy & Regulatory Framework
- 2.6. Industry Experts Views
- 3. Research Methodology
- 3.1. Secondary Research
- 3.2. Primary Data Collection
- 3.3. Market Formation & Validation
- 3.4. Report Writing, Quality Check & Delivery
- 4. Market Structure
- 4.1. Market Considerate
- 4.2. Assumptions
- 4.3. Limitations
- 4.4. Abbreviations
- 4.5. Sources
- 4.6. Definitions
- 5. Economic /Demographic Snapshot
- 6. Global Blood Collection Devices Market Outlook
- 6.1. Market Size By Value
- 6.2. Market Share By Region
- 6.3. Market Size and Forecast, By Geography
- 6.4. Market Size and Forecast, By Product Type
- 6.5. Market Size and Forecast, By End-User
- 6.6. Market Size and Forecast, By Application
- 6.7. Market Size and Forecast, By Method
- 7. North America Blood Collection Devices Market Outlook
- 7.1. Market Size By Value
- 7.2. Market Share By Country
- 7.3. Market Size and Forecast, By Product Type
- 7.4. Market Size and Forecast, By End-User
- 7.5. Market Size and Forecast, By Application
- 7.6. Market Size and Forecast, By Method
- 7.7. United States Blood Collection Devices Market Outlook
- 7.7.1. Market Size by Value
- 7.7.2. Market Size and Forecast By Product Type
- 7.7.3. Market Size and Forecast By End-User
- 7.7.4. Market Size and Forecast By Application
- 7.7.5. Market Size and Forecast By Method
- 7.8. Canada Blood Collection Devices Market Outlook
- 7.8.1. Market Size by Value
- 7.8.2. Market Size and Forecast By Product Type
- 7.8.3. Market Size and Forecast By End-User
- 7.8.4. Market Size and Forecast By Application
- 7.8.5. Market Size and Forecast By Method
- 7.9. Mexico Blood Collection Devices Market Outlook
- 7.9.1. Market Size by Value
- 7.9.2. Market Size and Forecast By Product Type
- 7.9.3. Market Size and Forecast By End-User
- 7.9.4. Market Size and Forecast By Application
- 7.9.5. Market Size and Forecast By Method
- 8. Europe Blood Collection Devices Market Outlook
- 8.1. Market Size By Value
- 8.2. Market Share By Country
- 8.3. Market Size and Forecast, By Product Type
- 8.4. Market Size and Forecast, By End-User
- 8.5. Market Size and Forecast, By Application
- 8.6. Market Size and Forecast, By Method
- 8.7. Germany Blood Collection Devices Market Outlook
- 8.7.1. Market Size by Value
- 8.7.2. Market Size and Forecast By Product Type
- 8.7.3. Market Size and Forecast By End-User
- 8.7.4. Market Size and Forecast By Application
- 8.7.5. Market Size and Forecast By Method
- 8.8. United Kingdom (UK) Blood Collection Devices Market Outlook
- 8.8.1. Market Size by Value
- 8.8.2. Market Size and Forecast By Product Type
- 8.8.3. Market Size and Forecast By End-User
- 8.8.4. Market Size and Forecast By Application
- 8.8.5. Market Size and Forecast By Method
- 8.9. France Blood Collection Devices Market Outlook
- 8.9.1. Market Size by Value
- 8.9.2. Market Size and Forecast By Product Type
- 8.9.3. Market Size and Forecast By End-User
- 8.9.4. Market Size and Forecast By Application
- 8.9.5. Market Size and Forecast By Method
- 8.10. Italy Blood Collection Devices Market Outlook
- 8.10.1. Market Size by Value
- 8.10.2. Market Size and Forecast By Product Type
- 8.10.3. Market Size and Forecast By End-User
- 8.10.4. Market Size and Forecast By Application
- 8.10.5. Market Size and Forecast By Method
- 8.11. Spain Blood Collection Devices Market Outlook
- 8.11.1. Market Size by Value
- 8.11.2. Market Size and Forecast By Product Type
- 8.11.3. Market Size and Forecast By End-User
- 8.11.4. Market Size and Forecast By Application
- 8.11.5. Market Size and Forecast By Method
- 8.12. Russia Blood Collection Devices Market Outlook
- 8.12.1. Market Size by Value
- 8.12.2. Market Size and Forecast By Product Type
- 8.12.3. Market Size and Forecast By End-User
- 8.12.4. Market Size and Forecast By Application
- 8.12.5. Market Size and Forecast By Method
- 9. Asia-Pacific Blood Collection Devices Market Outlook
- 9.1. Market Size By Value
- 9.2. Market Share By Country
- 9.3. Market Size and Forecast, By Product Type
- 9.4. Market Size and Forecast, By End-User
- 9.5. Market Size and Forecast, By Application
- 9.6. Market Size and Forecast, By Method
- 9.7. China Blood Collection Devices Market Outlook
- 9.7.1. Market Size by Value
- 9.7.2. Market Size and Forecast By Product Type
- 9.7.3. Market Size and Forecast By End-User
- 9.7.4. Market Size and Forecast By Application
- 9.7.5. Market Size and Forecast By Method
- 9.8. Japan Blood Collection Devices Market Outlook
- 9.8.1. Market Size by Value
- 9.8.2. Market Size and Forecast By Product Type
- 9.8.3. Market Size and Forecast By End-User
- 9.8.4. Market Size and Forecast By Application
- 9.8.5. Market Size and Forecast By Method
- 9.9. India Blood Collection Devices Market Outlook
- 9.9.1. Market Size by Value
- 9.9.2. Market Size and Forecast By Product Type
- 9.9.3. Market Size and Forecast By End-User
- 9.9.4. Market Size and Forecast By Application
- 9.9.5. Market Size and Forecast By Method
- 9.10. Australia Blood Collection Devices Market Outlook
- 9.10.1. Market Size by Value
- 9.10.2. Market Size and Forecast By Product Type
- 9.10.3. Market Size and Forecast By End-User
- 9.10.4. Market Size and Forecast By Application
- 9.10.5. Market Size and Forecast By Method
- 9.11. South Korea Blood Collection Devices Market Outlook
- 9.11.1. Market Size by Value
- 9.11.2. Market Size and Forecast By Product Type
- 9.11.3. Market Size and Forecast By End-User
- 9.11.4. Market Size and Forecast By Application
- 9.11.5. Market Size and Forecast By Method
- 10. South America Blood Collection Devices Market Outlook
- 10.1. Market Size By Value
- 10.2. Market Share By Country
- 10.3. Market Size and Forecast, By Product Type
- 10.4. Market Size and Forecast, By End-User
- 10.5. Market Size and Forecast, By Application
- 10.6. Market Size and Forecast, By Method
- 10.7. Brazil Blood Collection Devices Market Outlook
- 10.7.1. Market Size by Value
- 10.7.2. Market Size and Forecast By Product Type
- 10.7.3. Market Size and Forecast By End-User
- 10.7.4. Market Size and Forecast By Application
- 10.7.5. Market Size and Forecast By Method
- 10.8. Argentina Blood Collection Devices Market Outlook
- 10.8.1. Market Size by Value
- 10.8.2. Market Size and Forecast By Product Type
- 10.8.3. Market Size and Forecast By End-User
- 10.8.4. Market Size and Forecast By Application
- 10.8.5. Market Size and Forecast By Method
- 10.9. Colombia Blood Collection Devices Market Outlook
- 10.9.1. Market Size by Value
- 10.9.2. Market Size and Forecast By Product Type
- 10.9.3. Market Size and Forecast By End-User
- 10.9.4. Market Size and Forecast By Application
- 10.9.5. Market Size and Forecast By Method
- 11. Middle East & Africa Blood Collection Devices Market Outlook
- 11.1. Market Size By Value
- 11.2. Market Share By Country
- 11.3. Market Size and Forecast, By Product Type
- 11.4. Market Size and Forecast, By End-User
- 11.5. Market Size and Forecast, By Application
- 11.6. Market Size and Forecast, By Method
- 11.7. United Arab Emirates (UAE) Blood Collection Devices Market Outlook
- 11.7.1. Market Size by Value
- 11.7.2. Market Size and Forecast By Product Type
- 11.7.3. Market Size and Forecast By End-User
- 11.7.4. Market Size and Forecast By Application
- 11.7.5. Market Size and Forecast By Method
- 11.8. Saudi Arabia Blood Collection Devices Market Outlook
- 11.8.1. Market Size by Value
- 11.8.2. Market Size and Forecast By Product Type
- 11.8.3. Market Size and Forecast By End-User
- 11.8.4. Market Size and Forecast By Application
- 11.8.5. Market Size and Forecast By Method
- 11.9. South Africa Blood Collection Devices Market Outlook
- 11.9.1. Market Size by Value
- 11.9.2. Market Size and Forecast By Product Type
- 11.9.3. Market Size and Forecast By End-User
- 11.9.4. Market Size and Forecast By Application
- 11.9.5. Market Size and Forecast By Method
- 12. Competitive Landscape
- 12.1. Competitive Dashboard
- 12.2. Business Strategies Adopted by Key Players
- 12.3. Key Players Market Share Insights and Analysis, 2025
- 12.4. Key Players Market Positioning Matrix
- 12.5. Porter's Five Forces
- 12.6. Company Profile
- 12.6.1. BD
- 12.6.1.1. Company Snapshot
- 12.6.1.2. Company Overview
- 12.6.1.3. Financial Highlights
- 12.6.1.4. Geographic Insights
- 12.6.1.5. Business Segment & Performance
- 12.6.1.6. Product Portfolio
- 12.6.1.7. Key Executives
- 12.6.1.8. Strategic Moves & Developments
- 12.6.2. Terumo Corporation
- 12.6.3. Cardinal Health
- 12.6.4. Greiner Bio-One International GmbH
- 12.6.5. Fresenius Kabi AG
- 12.6.6. Haemonetics Corporation
- 12.6.7. McKesson Corporation
- 12.6.8. Medline Industries LP
- 12.6.9. Nipro Corporation
- 12.6.10. Sarstedt AG & Co. KG
- 12.6.11. Thermo Fisher Scientific Inc.
- 12.6.12. Sol-Millennium Medical Group
- 12.6.13. ICU Medical Inc.
- 12.6.14. Qiagen NV
- 12.6.15. Abbott
- 12.6.16. F.L. Medical S.r.l.
- 12.6.17. Macopharma S.A.
- 12.6.18. Kawasumi Laboratories, Inc.
- 12.6.19. Retractable Technologies, Inc.
- 12.6.20. Sekisui Medical Co., Ltd.
- 13. Strategic Recommendations
- 14. Annexure
- 14.1. FAQ`s
- 14.2. Notes
- 15. Disclaimer
Table 2: Influencing Factors for Blood Collection Devices Market, 2025
Table 3: Top 10 Counties Economic Snapshot 2024
Table 4: Economic Snapshot of Other Prominent Countries 2022
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Blood Collection Devices Market Size and Forecast, By Geography (2020 to 2031F) (In USD Billion)
Table 7: Global Blood Collection Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 8: Global Blood Collection Devices Market Size and Forecast, By End-User (2020 to 2031F) (In USD Billion)
Table 9: Global Blood Collection Devices Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 10: Global Blood Collection Devices Market Size and Forecast, By Method (2020 to 2031F) (In USD Billion)
Table 11: North America Blood Collection Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 12: North America Blood Collection Devices Market Size and Forecast, By End-User (2020 to 2031F) (In USD Billion)
Table 13: North America Blood Collection Devices Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 14: North America Blood Collection Devices Market Size and Forecast, By Method (2020 to 2031F) (In USD Billion)
Table 15: United States Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 16: United States Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 17: United States Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 18: United States Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 19: Canada Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 20: Canada Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 21: Canada Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 22: Canada Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 23: Mexico Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 24: Mexico Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 25: Mexico Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 26: Mexico Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 27: Europe Blood Collection Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 28: Europe Blood Collection Devices Market Size and Forecast, By End-User (2020 to 2031F) (In USD Billion)
Table 29: Europe Blood Collection Devices Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 30: Europe Blood Collection Devices Market Size and Forecast, By Method (2020 to 2031F) (In USD Billion)
Table 31: Germany Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 32: Germany Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 33: Germany Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 34: Germany Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 35: United Kingdom (UK) Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 36: United Kingdom (UK) Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 37: United Kingdom (UK) Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 38: United Kingdom (UK) Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 39: France Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 40: France Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 41: France Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 42: France Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 43: Italy Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 44: Italy Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 45: Italy Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 46: Italy Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 47: Spain Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 48: Spain Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 49: Spain Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 50: Spain Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 51: Russia Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 52: Russia Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 53: Russia Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 54: Russia Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 55: Asia-Pacific Blood Collection Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 56: Asia-Pacific Blood Collection Devices Market Size and Forecast, By End-User (2020 to 2031F) (In USD Billion)
Table 57: Asia-Pacific Blood Collection Devices Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 58: Asia-Pacific Blood Collection Devices Market Size and Forecast, By Method (2020 to 2031F) (In USD Billion)
Table 59: China Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 60: China Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 61: China Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 62: China Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 63: Japan Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 64: Japan Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 65: Japan Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 66: Japan Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 67: India Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 68: India Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 69: India Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 70: India Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 71: Australia Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 72: Australia Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 73: Australia Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 74: Australia Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 75: South Korea Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 76: South Korea Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 77: South Korea Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 78: South Korea Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 79: South America Blood Collection Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 80: South America Blood Collection Devices Market Size and Forecast, By End-User (2020 to 2031F) (In USD Billion)
Table 81: South America Blood Collection Devices Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 82: South America Blood Collection Devices Market Size and Forecast, By Method (2020 to 2031F) (In USD Billion)
Table 83: Brazil Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 84: Brazil Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 85: Brazil Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 86: Brazil Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 87: Argentina Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 88: Argentina Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 89: Argentina Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 90: Argentina Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 91: Colombia Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 92: Colombia Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 93: Colombia Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 94: Colombia Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 95: Middle East & Africa Blood Collection Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 96: Middle East & Africa Blood Collection Devices Market Size and Forecast, By End-User (2020 to 2031F) (In USD Billion)
Table 97: Middle East & Africa Blood Collection Devices Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 98: Middle East & Africa Blood Collection Devices Market Size and Forecast, By Method (2020 to 2031F) (In USD Billion)
Table 99: United Arab Emirates (UAE) Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 100: United Arab Emirates (UAE) Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 101: United Arab Emirates (UAE) Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 102: United Arab Emirates (UAE) Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 103: Saudi Arabia Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 104: Saudi Arabia Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 105: Saudi Arabia Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 106: Saudi Arabia Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 107: South Africa Blood Collection Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 108: South Africa Blood Collection Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 109: South Africa Blood Collection Devices Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 110: South Africa Blood Collection Devices Market Size and Forecast By Method (2020 to 2031F) (In USD Billion)
Table 111: Competitive Dashboard of top 5 players, 2025
Table 112: Key Players Market Share Insights and Analysis for Blood Collection Devices Market 2025
Figure 2: Market attractiveness Index, By Region 2031F
Figure 3: Market attractiveness Index, By Segment 2031F
Figure 4: Global Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 5: Global Blood Collection Devices Market Share By Region (2025)
Figure 6: North America Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 7: North America Blood Collection Devices Market Share By Country (2025)
Figure 8: US Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 9: Canada Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 10: Mexico Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 11: Europe Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 12: Europe Blood Collection Devices Market Share By Country (2025)
Figure 13: Germany Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 14: United Kingdom (UK) Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 15: France Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 16: Italy Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 17: Spain Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 18: Russia Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 19: Asia-Pacific Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 20: Asia-Pacific Blood Collection Devices Market Share By Country (2025)
Figure 21: China Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 22: Japan Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 23: India Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 24: Australia Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 25: South Korea Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 26: South America Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 27: South America Blood Collection Devices Market Share By Country (2025)
Figure 28: Brazil Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 29: Argentina Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 30: Colombia Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 31: Middle East & Africa Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 32: Middle East & Africa Blood Collection Devices Market Share By Country (2025)
Figure 33: United Arab Emirates (UAE) Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 34: Saudi Arabia Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 35: South Africa Blood Collection Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 36: Porter's Five Forces of Global Blood Collection Devices Market
Blood Collection Devices Market Research FAQs
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Our Clients
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (02 September, 2026)
- Notify To Team (02 September, 2026)
- Report updation (03 September, 2026)
- Report Quality Check (03 September, 2026)
- Report Dispatch (04 September, 2026)
- Hard Copy
Recently Viewed Products
Global Blood Collection Devices Market Outlook, 2031
We are friendly and approachable, give us a call.